retatrutide high blood pressure UK 2026: Phase 3 Results does retatrutide affect blood pressure

Enlist support

Although investigational methods such as intranasal or inhaled formulations are still in their initial development phase, they illustrate a widespread initiative to develop alternatives to injection-based treatments

For many patients, the weekly schedule is one of the biggest advantages

Retatrutide may become the high-efficacy benchmark if Phase 3 and regulatory review support the early signal

As bariatric and nutritional specialists, we often see patients make the same mistake

Eli Lilly held approximately 57% of the market as of early 2025, with Novo Nordisk trailing slightly behind as it grapples with supply constraints